Ki-67 expression in early prostate cancer and associated pathological lesions.
Open Access
- 1 September 1996
- journal article
- case report
- Published by BMJ in Journal of Clinical Pathology
- Vol. 49 (9), 741-748
- https://doi.org/10.1136/jcp.49.9.741
Abstract
AIM: To assess cell proliferation in early prostate cancer and associated pathological lesions. METHODS: Using the Ki-67 antibody, the cell proliferation index was measured in early stage prostatic carcinoma in 37 incidental tumours diagnosed at transurethral prostatectomy (TURP) and in 20 low volume cancers treated by radical prostatectomy. Proliferation indexes have also been measured in areas of normal peripheral zone, transition zone hyperplasia, atrophic appearing lobules, and high grade prostatic intraepithelial neoplasia in the radical prostatectomy cases. RESULTS: In the TURP series the proliferation index correlated with grade and stage. Logistic regression analysis, however, showed that Gleason grade was the most reliable predictor of biopsy proven residual disease and clinical progression. In the radical series transition zone carcinoma the proliferation index was half that of peripheral zone carcinoma. The atrophic lobules also showed a high proliferation index of the same order as seen in the peripheral zone carcinoma. Normal peripheral zone showed the lowest proliferation index and in hyperplastic transition zone it was also less than the other areas. CONCLUSIONS: There is only limited support for the correlation of proliferation index with grade in early stage prostatic carcinoma. The findings do not suggest that proliferation index adds to the prognostic information given by grade and stage in pT1 disease. The significant difference in proliferation index in transition zone and peripheral zone carcinomas supports the morphological distinction of these tumour types and is consistent with differences in biological behaviour. The high proliferation index in lobules considered morphologically atrophic is reminiscent of previous observations in which carcinoma was spatially associated with atrophy.Keywords
This publication has 41 references indexed in Scilit:
- Assessment of cell proliferation in pathology—what next?Histopathology, 1995
- Post‐operative serial prostate‐specific antigen and transrectal ultrasound for staging incidental carcinoma of the prostateBritish Journal of Urology, 1995
- Brief, high‐temperature heat denaturation (pressure cooking): A simple and effective method of antigen retrieval for routinely processed tissuesThe Journal of Pathology, 1994
- Proliferative activity determined by DNA flow cytometry and proliferating cell nuclear antigen (PCNA) immunohistochemistry as a prognostic factor in prostatic carcinomaThe Journal of Pathology, 1992
- P53 and Ki‐67 Immunoreactivity in Human Prostate Cancer and Benign HyperplasiaBritish Journal of Urology, 1992
- Relationship of proliferating cell nuclear antigen (PCNA) in prostatic carcinomas to various clinical parametersThe Prostate, 1992
- Nucleolar Organizer Regions (NOR) in Hyperplastic and Neoplastic Prostate DiseaseThe American Journal of Surgical Pathology, 1990
- Growth fractions in human prostatic carcinoma determined by Ki‐67 immunostainingThe Journal of Pathology, 1988
- ATROPHY AND REGENERATION IN THE PATHOGENESIS OF PROSTATIC CARCINOMAActa Pathologica Microbiologica Scandinavica, 1968
- Latent carcinoma of the prostateThe Journal of Pathology and Bacteriology, 1954